CI
CMRX

Cigna Investments’s Chimerix, Inc. CMRX Stock Holding History

Cigna Investments’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-64,395
Closed -$411K – 862
2017
Q1 		$411K Sell
64,395
-28,695
-31% -$163K 0.03% 496
2016
Q4 		$428K Buy
+93,090
New +$439K 0.05% 447

Other funds holding CMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Cigna Investments's CMRX Position: Q2 2017 in Review

Cigna Investments sold out of Chimerix, Inc. (CMRX) in Q2 2017, closing a stake of 64,395 shares — an estimated $411K sold.

Cigna Investments first reported a position in CMRX in Q4 2016 and held it in 2 quarters. The position peaked at $428K in Q4 2016. 100 funds tracked by Wall St. Rank hold CMRX as of Q2 2017.

  • Cigna Investments reported no remaining Chimerix, Inc. position as of Q2 2017 after selling out during the quarter.
  • Cigna Investments sold 64,395 Chimerix, Inc. shares in Q2 2017, an estimated $411K.
  • Cigna Investments first reported a position in Chimerix, Inc. in Q4 2016 and held it in 2 quarters.
  • Cigna Investments's Chimerix, Inc. position peaked at $428K in Q4 2016.
  • 100 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2017.

Based on Cigna Investments's 13F filing for Q2 2017, filed 1 Aug 2017.